ALX-1393

CAS No. 949164-09-4

ALX-1393( —— )

Catalog No. M33260 CAS No. 949164-09-4

ALX-1393 is a selective GlyT2 inhibitor that effectively reduces neuronal action potential activity in a concentration-dependent manner and inhibits the activity of spontaneous networks by inducing glycinergic tetanic currents in the abdominal horn of the spinal cord.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 2098 In Stock
5MG 2660 In Stock
10MG 3591 In Stock
25MG 5170 In Stock
50MG 6983 In Stock
100MG 8883 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ALX-1393
  • Note
    Research use only, not for human use.
  • Brief Description
    ALX-1393 is a selective GlyT2 inhibitor that effectively reduces neuronal action potential activity in a concentration-dependent manner and inhibits the activity of spontaneous networks by inducing glycinergic tetanic currents in the abdominal horn of the spinal cord.
  • Description
    ALX-1393, a selective GlyT2 inhibitor, has an antinociceptive effect on thermal, mechanical, and chemical stimulations in a rat acute pain model.
  • In Vitro
    ——
  • In Vivo
    ALX1393 (i.c.v.; 25, 50, and 100 μg) in normal rats suppresses the late-phase response in the formalin test but does not affect motor performance. ALX1393 inhibits mechanical and cold hyperalgesia in a dose-dependent manner.
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    GlyT
  • Recptor
    GlyT
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    949164-09-4
  • Formula Weight
    395.42
  • Molecular Formula
    C23H22FNO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(OC[C@@H](C(O)=O)N)(C1=C(OCC2=CC=CC=C2)C=CC=C1)C3=CC(F)=CC=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Haranishi Y, et al. The antinociceptive effect of intrathecal administration of glycine transporter-2 inhibitor ALX1393 in a rat acute pain model. Anesth Analg. 2010 Feb 1;110(2):615-21.?
molnova catalog
related products
  • PF-03463275 B

    PF-03463275 is an orally active and selective reversible inhibitor of competitive glycine transporter protein-1 (GlyT1) with a Ki of 11.6 nM.

  • Bitopertin R enantio...

    A potent and selective GlyT1 inhibitor with EC50 of 54 nM.

  • PF-03463275

    PF-03463275 (PF 3463275) ia an orally bioavailable, centrally penetrant, potent, reversible, selective, and competitive inhibitor of the human GlyT1 transporter with Ki of 13 nM.